SciClone Pharmaceuticals

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

SciClone is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs for treating chronic and life-threatening diseases, such as hepatitis B, hepatitis C, cancer, immune system disorders and cystic fibrosis.

Contact Details: 901 Mariner's Island Boulevard, Suite 205 San Mateo CA 94404 United States of America Tel: 650 358 3456 Fax: 650 358 3469 Email: investorrelations@sciclone.com WWW: www.sciclone.com/

Loading...

Recent Publications by SciClone Pharmaceuticals:
Issues in pharmaceutical development of thymosin alpha1 from preclinical studies through marketing. SciClone Pharmaceuticals licensed the commercial and patent rights to...	28th December, 2007	SciClone Pharmaceuticals, Inc., 901 Mariner's Island Blvd., San Mateo, CA	Ann N Y Acad Sci. 2007 Sep;1112:351-6. DOI Direct Link
Comparison of assays for determination of peptide content for lyophilized thymalfasin. Precise determination of the peptide content in drug substance samples...	3rd August, 2005	SciClone Pharmaceuticals, Inc., 901 Mariner's Island Blvd, San Mateo, CA	J Pept Res. 2005 Apr;65(4):433-9. DOI Direct Link
Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS. A high performance liquid chromatography with tandem mass spectrometry...	11th February, 2004	SciClone Pharmaceuticals, Inc. 901 Mariner's Island Blvd., San Mateo, CA	AAPS PharmSciTech. 2000 May 14;1(2):E11. DOI Direct Link

BioNews Results for SciClone Pharmaceuticals:
Final Call to Register for BioPartnering Europe (BPE)	Reuters:  Oct 2 2008 9:37PM Matching: sciclone pharmaceuticals
Final Call to Register for BioPartnering Europe (BPE)	Business Wire via Yahoo!:  Oct 2 2008 9:29PM Matching: sciclone pharmaceuticals
New drug promising in HCV infection: SciClone	PharmaBiz:  Sep 26 2008 1:52PM Matching: sciclone pharmaceuticals
Conference Calls: SciClone Pharmaceuticals, Inc	BestCalls:  Sep 25 2008 7:52PM Matching: sciclone pharmaceuticals
SciClone Pharmaceuticals To Present At UBS Global Life Sciences Conference; Webcast At 1:00 PM	RTTNews.com:  Sep 25 2008 5:55PM Matching: sciclone pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more SciClone Pharmaceuticals news.

SciClone Pharmaceuticals Patents:
US Patent No.	Title
7297676	Thymosin alpha 1 peptide/polymer conjugates
5849696	Composition and method of treating hepatitis C
5939423	Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
6001799	Method of treating hepatitis C in non-responders to interferon treatment
6200952	Combination therapy method for treating chronic hepatitis B
→View more SciClone Pharmaceuticals patents.

SciClone Pharmaceuticals (SCLN) Financial information Links from Barchart
SCLN Quote from from Barchart.com
SCLN Chart from from Barchart.com
SCLN Profile from from Barchart.com
SCLN Opinion from from Barchart.com
→View more SciClone Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 131 times since April 2007, the link to the organisation's website has been followed 23 times

Search for more companies in San Mateo

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SciClone Pharmaceuticals

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.